These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
784 related items for PubMed ID: 19147306
1. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment. Gauthier I, Carrier JF, Béliveau-Nadeau D, Fortin B, Taussky D. Int J Radiat Oncol Biol Phys; 2009 Jul 15; 74(4):1128-33. PubMed ID: 19147306 [Abstract] [Full Text] [Related]
7. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Tucker SL, Dong L, Cheung R, Johnson J, Mohan R, Huang EH, Liu HH, Thames HD, Kuban D. Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1589-601. PubMed ID: 15590191 [Abstract] [Full Text] [Related]
8. The comparison of radiotherapy techniques for treatment of the prostate cancer: the three-field vs. the four-field. Milecki P, Piotrowski T, Dymnicka M. Neoplasma; 2004 Dec 01; 51(1):64-9. PubMed ID: 15004663 [Abstract] [Full Text] [Related]
9. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Vargas C, Martinez A, Kestin LL, Yan D, Grills I, Brabbins DS, Lockman DM, Liang J, Gustafson GS, Chen PY, Vicini FA, Wong JW. Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1297-308. PubMed ID: 16029785 [Abstract] [Full Text] [Related]
12. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. Teh BS, Dong L, McGary JE, Mai WY, Grant W, Butler EB. Med Dosim; 2005 Aug 01; 30(1):25-30. PubMed ID: 15749008 [Abstract] [Full Text] [Related]
13. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients. Kassim I, Dirkx ML, Heijmen BJ. Radiother Oncol; 2009 Jul 01; 92(1):62-7. PubMed ID: 19278745 [Abstract] [Full Text] [Related]
14. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer. O'Neill L, Armstrong J, Buckney S, Assiri M, Cannon M, Holmberg O. Radiother Oncol; 2008 Jul 01; 88(1):61-6. PubMed ID: 18453021 [Abstract] [Full Text] [Related]
19. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer. Koper PC, Heemsbergen WD, Hoogeman MS, Jansen PP, Hart GA, Wijnmaalen AJ, van Os M, Boersma LJ, Lebesque JV, Levendag P. Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1072-82. PubMed ID: 15001247 [Abstract] [Full Text] [Related]
20. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer. Luo C, Yang CC, Narayan S, Stern RL, Perks J, Goldberg Z, Ryu J, Purdy JA, Vijayakumar S. Int J Radiat Oncol Biol Phys; 2006 Nov 15; 66(4):1253-62. PubMed ID: 17145540 [Abstract] [Full Text] [Related] Page: [Next] [New Search]